Premium
Angiotensin II (ANGII) and endothelin‐1 (ET‐1) induction of MYC and AP‐1 transcription factor binding activity in vascular smooth muscle cells (VSMCs) is reversed by nitric oxide (NO)
Author(s) -
Andrawis N.S.,
Hackenbruck J.,
Li Y.,
Abemethy D. R.
Publication year - 1996
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.1996.204
Subject(s) - vascular smooth muscle , angiotensin ii , nitric oxide , chemistry , pharmacology , endothelin 1 , cyclic gmp , transcription factor , endothelin receptor , medicine , endocrinology , smooth muscle , biology , receptor , biochemistry , gene
Clinical Pharmacology & Therapeutics (1996) 59 , 176–176; doi: 10.1038/sj.clpt.1996.204